Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Herlev Hospital currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is confined to 1 distinct examiner and 1 distinct art unit. The hospital's current intellectual property efforts are focused on this 1 active matter. With 1 pending office action, the hospital can ensure that its response is tailored to the specific requirements of the biotechnology sector.
The busiest examiner for the hospital is FLINDERS, JEREMY C, who has 1 pending office action. This count represents the total of pending actions for the entity. Practitioners must tailor their approach to the specific standards of FLINDERS, JEREMY C to successfully navigate the biotechnology examination process. The 1 distinct art unit involved will play a key role in determining the patentability of the hospital's innovations.
The presence of 1 pending office action indicates a very specific point of contact with the patent office. Practitioners should carefully analyze the feedback from the examiner to address any technical rejections. The outcome of the matter assigned to FLINDERS, JEREMY C will be the primary factor in the hospital's current patent prosecution success in the Biotechnology & Pharmaceuticals field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLINDERS, JEREMY C | 1 | 63.5% | +16.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18304028 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules | FLINDERS, JEREMY C | — |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18304028 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules | FLINDERS, JEREMY C | 1684 | §103DP | Non-Final OA | — | Pending | Apr 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial